FEops offers a unique pre-operative planning platform for structural heart interventions based on personalized predictive modelling. This scalable, automated and AI-enabled cloud-based platform contributes to better clinical outcome and improved procedure efficiency, and fosters market penetration and therapy adoption. FEops HEARTguide™ surpasses basic anatomical measurement, generating accurate predictions of how devices will interact with each unique patient. It is CE marked product with indication for use in TAVI (incl BAV patients) and LAAo.

Our cloud-based centralized platform houses the variable anatomy from hundreds of real patients and can model current or future devices across a diverse group of patients, moving beyond traditional bench and pre-clinical models, offering a future in-silico platform for the physician training and clinical trial environment.

Our end-to-end solution adds value to optimize and accelerate every step in the structural heart product life cycle, helping manufacturers accelerate time to market and bringing physicians insights that contribute to better patient outcomes.

BREAKTHROUGH IDEA

• Create better implants faster

The proprietary predictive simulation technology that drives the FEops HEARTguide™ suite gives device manufacturers tremendous power to accelerate the development of novel minimally invasive structural heart implants. Introduce virtual patients or digital twins into your workflows before making physical prototypes to gain time, cut costs, and test in clinically relevant contexts.

• Accelerate clinical trials

By improving patient selection and optimally preparing physicians for procedures through detailed predictive simulations, FEops HEARTguide™ can accelerate clinical trials and potentially contribute to better patient outcomes.

• Launch products faster

Make it intuitive for physicians to adopt and endorse novel structural heart devices with FEops HEARTguide™. Inspire confidence and accelerate the learning curve by providing physicians with predictive 3D images that demonstrate how the device will interact with the unique anatomy of each patient – without putting patients at risk.

• Bring patients better structural heart outcomes

In going beyond anatomical measurement, only FEops HEARTguide™ provides detailed preoperative insights into the interaction between the implant and the patient’s anatomy. This helps physicians to assist in the selection of device size and positioning.

POSITIVE IMPACT ON THE SOCIETY

GOAL 3 : GOOD HEALTH AND WELL-BEING

FEops ensures healthy lives and promote well-being for all at all ages. FEops HEARTguide cloud-based procedure planning environment uses predictive simulation to provide clinicians and medical device manufacturers with first-ever insights into the interaction between transcatheter structural heart devices and specific patient anatomy –preoperatively

BENEFITS TO USE THE 3DEXPERIENCE PLATFORM ON THE CLOUD

• On-demand, cloud-based software and hardware facilities that will be essential for scalability and streamlined delivery of FEops HEARTguide™
• 3D multiphysics simulation for the most accurate and personalized predictive insights into patients’ device-heart interactions
• The potential to incorporate data science and machine learning into FEops HEARTguide™ processes thereby significantly reducing turnaround times